BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9517941)

  • 21. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine.
    Rossi L; Serafini S; Franchetti P; Casabianca A; Orlandi C; Schiavano GF; Carnevali A; Magnani M
    J Antimicrob Chemother; 2002 Nov; 50(5):639-47. PubMed ID: 12407119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of 9-[(R)-2-[[(S)-[[(S)-1-(Isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and other tenofovir phosphonoamidate prodrugs by human proteases.
    Birkus G; Kutty N; He GX; Mulato A; Lee W; McDermott M; Cihlar T
    Mol Pharmacol; 2008 Jul; 74(1):92-100. PubMed ID: 18430788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems.
    Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E
    Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.
    Deeks SG; Barditch-Crovo P; Lietman PS; Hwang F; Cundy KC; Rooney JF; Hellmann NS; Safrin S; Kahn JO
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2380-4. PubMed ID: 9736567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.
    Birkus G; Hájek M; Kramata P; Votruba I; Holý A; Otová B
    Antimicrob Agents Chemother; 2002 May; 46(5):1610-3. PubMed ID: 11959615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution.
    Oliyai R; Yuan LC; Dahl T
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1295-8. PubMed ID: 11563007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.
    Tsai CC; Emau P; Follis KE; Beck TW; Benveniste RE; Bischofberger N; Lifson JD; Morton WR
    J Virol; 1998 May; 72(5):4265-73. PubMed ID: 9557716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane-permeable tenofovir-di- and monophosphate analogues.
    Jia X; Kullik GA; Bufano M; Brancale A; Schols D; Meier C
    Eur J Med Chem; 2024 Jan; 264():116020. PubMed ID: 38086193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques.
    Silvera P; Racz P; Racz K; Bischofberger N; Crabbs C; Yalley-Ogunro J; Greenhouse J; Jiang JB; Lewis MG
    AIDS Res Hum Retroviruses; 2000 May; 16(8):791-800. PubMed ID: 10826485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.
    Palmer S; Margot N; Gilbert H; Shaw N; Buckheit R; Miller M
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1167-73. PubMed ID: 11522186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
    Cundy KC; Sueoka C; Lynch GR; Griffin L; Lee WA; Shaw JP
    Antimicrob Agents Chemother; 1998 Mar; 42(3):687-90. PubMed ID: 9517952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
    Mackman RL; Zhang L; Prasad V; Boojamra CG; Douglas J; Grant D; Hui H; Kim CU; Laflamme G; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
    Bioorg Med Chem; 2007 Aug; 15(16):5519-28. PubMed ID: 17562366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.
    Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC
    J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production.
    Zídek Z; Holý A; Franková D
    Eur J Pharmacol; 1997 Jul; 331(2-3):245-52. PubMed ID: 9274986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
    Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.
    Murry JP; Higgins J; Matthews TB; Huang VY; Van Rompay KK; Pedersen NC; North TW
    J Virol; 2003 Jan; 77(2):1120-30. PubMed ID: 12502828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.
    Tsai CC; Follis KE; Sabo A; Beck TW; Grant RF; Bischofberger N; Benveniste RE; Black R
    Science; 1995 Nov; 270(5239):1197-9. PubMed ID: 7502044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.
    Tarantal AF; Marthas ML; Shaw JP; Cundy K; Bischofberger N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(4):323-33. PubMed ID: 10096575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques.
    Van Rompay KK; Cherrington JM; Marthas ML; Berardi CJ; Mulato AS; Spinner A; Tarara RP; Canfield DR; Telm S; Bischofberger N; Pedersen NC
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2586-91. PubMed ID: 8913470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication.
    Pisarev VM; Lee SH; Connelly MC; Fridland A
    Mol Pharmacol; 1997 Jul; 52(1):63-8. PubMed ID: 9224813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.